Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE991.8010.3 (+1.05 %)

PREV CLOSE ( ) 981.50

OPEN PRICE ( ) 986.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 994.20 (1)

VOLUME 5988

TODAY'S LOW / HIGH ( )975.00 999.10

52 WK LOW / HIGH ( )551 1024.9

NSE994.1013.05 (+1.33 %)

PREV CLOSE( ) 981.05

OPEN PRICE ( ) 980.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 994.10 (25)

VOLUME 188937

TODAY'S LOW / HIGH( ) 972.50 999.90

52 WK LOW / HIGH ( )513.05 1025

Chairman	Arun Kumar
Managing Director	Badree Komandur
Company Secretary	Manjula Ramamurthy
Non Executive Independent Director	Kausalya Santhanam Homi Rustam Khusrokhan Subir Chakraborty Ameet Hariani Mukta Arora
Executive Director - Business Development	Aditya Kumar

Incorporation Year : 28-06 1990

Registered Office :

Address : Cyberone, Unit No. 902,Plot No - 4 & 6,Sector 30 A, Vashi Navi Mumbai,
Maharashtra-400703 .

Phone : 022-27892924 / 3199

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE